Acute asthma exacerbation in adults

When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Last reviewed: 26 Jul 2024
Last updated: 31 Aug 2023

Summary

Definition

History and exam

Key diagnostic factors

  • shortness of breath
  • cough
  • wheeze
  • risk factors
  • progressive chest tightness
  • progressive decrease in lung function
  • tachypnoea
  • tachycardia
  • silent chest
  • accessory muscle use
  • sleep disturbance
Full details

Other diagnostic factors

  • exercise limitation
  • collapse
  • altered consciousness
  • skin symptoms
  • cyanosis
  • arrhythmia
  • hypotension
  • exhaustion
  • stridor
Full details

Risk factors

  • viral infection
  • uncontrolled asthma symptoms
  • high use of short-acting beta-2 agonists
  • inadequate use of inhaled corticosteroids
  • incorrect inhaler technique
  • low forced expiratory volume in 1 second (FEV1)
  • high bronchodilator reversibility
  • current smoker (including e-cigarettes) or exposure to second-hand cigarette smoke
  • exposure to allergens (including history of seasonal allergic rhinitis)
  • air pollution
  • poor indoor air quality
  • obesity
  • chronic rhinosinusitis
  • gastro-oesophageal reflux disease
  • confirmed food allergy
  • history of asthma
  • history of hospitalisation for asthma exacerbations
  • one or more severe exacerbations in the last 12 months
  • use of oral corticosteroids
  • poor adherence to asthma treatment
  • pregnancy
  • psychological or socioeconomic problems
  • blood eosinophils
  • elevated fractional exhaled nitric oxide (FeNO)
  • respiratory bacterial infection
Full details

Diagnostic investigations

1st investigations to order

  • arterial blood gas (in hospital)
  • peak flow (in the community and in hospital)
  • pulse oximetry (in the community and in hospital)
  • chest x-ray (in hospital)
Full details

Investigations to consider

  • full blood count (in hospital)
  • urea and electrolytes (in hospital)
  • C-reactive protein (in hospital)
  • theophylline levels (in hospital)
  • ECG (in hospital)
Full details

Treatment algorithm

ACUTE

life-threatening exacerbation or impending respiratory failure

acute severe exacerbation

moderate exacerbation

ONGOING

symptomatic asthma post-stabilisation

Contributors

Expert advisers

Jonathan Bennett, MD

Honorary Professor of Respiratory Sciences

University of Leicester

Respiratory Consultant

Glenfield Hospital

Leicester

UK

Biography

JB is deputy medical director of the Royal College of Physicians (RCP) Invited Service Reviews, and speaker at national society meetings including the British Thoracic Society, the Primary Care Respiratory Society, and the Society for Cardiothoracic Surgery.

Disclosures

JB is deputy medical director of RCP Invited Service Reviews.

Richard Russell, MBBS, PhD, MRCP

Specialty Registrar in Respiratory Medicine

Glenfield Hospital

Leicester

UK

Disclosures

RR has received support from Chiesi, covering registration fee, travel, and accommodation, to attend a conference.

Acknowledgements

BMJ Best Practice would like to gratefully acknowledge the previous expert contributors, whose work has been retained in parts of the content:

Sourav Majumdar, MD

Clinical Assistant Professor (Affiliated)

Division of Pulmonary, Allergy and Critical Care Medicine

Department of Medicine

Stanford University School of Medicine

Stanford

Lauren Eggert, MD

Fellow

Division of Pulmonary, Allergy and Critical Care Medicine

Department of Medicine

Stanford University School of Medicine

Stanford

Disclosures

SM and LE declare that they have no competing interests.

Peer reviewers

Pujan H Patel, MD

Consultant in Respiratory Medicine

Royal Brompton Hospital

London

UK

Disclosures

PP has received speaker fees for educational lecture events from GlaxoSmithKline.

Editors

Emma Quigley

Section Editor, BMJ Best Practice

Disclosures

EQ declares that she has no competing interests.

Tannaz Aliabadi-Oglesby

Lead Section Editor, BMJ Best Practice

Disclosures

TAO declares that she has no competing interests.

Julie Costello

Comorbidities Editor, BMJ Best Practice

Disclosures

JC declares that she has no competing interests.

Adam Mitchell

Drug Editor, BMJ Best Practice

Disclosures

AM declares that he has no competing interests.

  • Differentials

    • Acute bronchiolitis
    • Pneumonia
    • Foreign body/obstruction
    More Differentials
  • Guidelines

    • Global strategy for asthma management and prevention
    • British guideline on the management of asthma
    More Guidelines
  • Calculators

    Glasgow Coma Scale

    More Calculators
  • Videos

    Peak flow measurement animated demonstration

    More videos
  • Patient information

    Asthma in adults: what is it?

    Asthma in adults: what treatments work?

    More Patient information
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer